The CDC recommends all healthy adults 50 years of age and older receive 2 doses of Shingrix® (recombinant zoster vaccine or RZV) 2-6 months apart regardless of a past episode of herpes zoster or receipt of Zostavax® (zoster vaccine live or ZVL).

Adults who previously received Zostavax® should get Shingrix®. They should wait at least 2 months after receiving Zostavax® to receive Shingrix®.

The CDC also continues to recommend adults aged 60 years or older, receive either available vaccine. However, Shingrix® is preferred the preferred choice of zoster vaccine.